Thanks for your insightful response TB.
For my part, I don't necessarily agree that the present share price dictates takeover price or timing. The share price is determined by the aggregate supply and demand for the stock at a given time. As others have suggested, I think it's likely that some profit-taking occurred after the Pitt Hopkins readout by those exiting before the Angelman results and longer-term developments. Regardless of the cause, the effect of that selling was to lower the share price.
On the other hand, a competitive takeover price is determined by the willingness to pay of the suitor(s) and the willingness to sell of the target. Given NNZ-2591's potential, as proved up by two positive Phase 2 trial results and preclinical studies in other indications, I do not think suitors will feel constrained by the present share price. They will simply express a willingness to pay which reflects some discount on their expected return from Daybue and NNZ-2591. If there is more than one potential suitor, things get more interesting in an auction-style bidding process.
That still leaves open the question of whether Neuren should court takeover interest now or expend some of its war chest getting NNZ-2591 FDA approval-ready first. Jon/management have not given an explicit indication of their preference, but my sense (speculation only) is that they are hoping to put a bow on the company this year.
Keen to hear what others think.
- Forums
- ASX - By Stock
- NEU
- Pipeline-in-a-drug
Pipeline-in-a-drug, page-11
-
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.65 |
Change
-0.540(2.81%) |
Mkt cap ! $2.383B |
Open | High | Low | Value | Volume |
$18.98 | $19.15 | $18.50 | $10.51M | 560.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $18.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.65 | 1127 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 18.530 |
4 | 1225 | 18.510 |
7 | 2678 | 18.500 |
2 | 1169 | 18.490 |
1 | 162 | 18.450 |
Price($) | Vol. | No. |
---|---|---|
19.080 | 300 | 1 |
19.150 | 150 | 1 |
19.200 | 899 | 2 |
19.240 | 550 | 1 |
19.340 | 1000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |